{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:23:06Z","timestamp":1795022586282,"version":"4.10.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The incidence of corrected QT interval (QTc) prolongation and torsades de pointes (TdP) in individuals undergoing methadone maintenance treatment (MMT) is a significant concern, as studies indicate that methadone can lead to these cardiac complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic search was performed across various databases including PubMed, Scopus, and Embase from January 2000 to July 2025. Risk of bias was assessed using the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) for observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty-two observational studies were included. The pooled mean age of patients undergoing MMT across the included studies was 40.8 years (95% confidence interval [CI]: 37.9\u201343.8). The overall pooled proportion of male participants across the included studies was 73% (95% CI: 66\u201381%). Incidence of QTc prolongation among patients on MMT showed a prevalence of 34% (95% CI: 24\u201343%). The pooled incidence of TdP was 2% (95% CI: 0\u20135%) after removing outlier study. The majority of evidence supports a dose-dependent relationship between methadone and QTc prolongation, though TdP remains rare and inconsistently linked to dose. This underscores the need for individualized dose titration and electrocardiogram monitoring, especially at higher daily doses (&gt;100\u2009mg).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MMT is associated with a substantial risk of QTc prolongation and a low but clinically relevant risk of TdP. Careful dose adjustment and regular electrocardiogram monitoring, particularly at higher doses, are essential to minimize cardiac complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045304","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:01:04Z","timestamp":1761332464000},"page":"e45304","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["QTc prolongation and torsades de pointes (TdP) in individuals undergoing methadone maintenance treatment (MMT): A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5361-6795","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Paknahad","sequence":"first","affiliation":[{"name":"Cardiology Department, Abadan University of Medical Science, Abadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Soleimani","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Echocardiography Department, Chamran Cardiovascular Medical and Research Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7544-6491","authenticated-orcid":false,"given":"Fatereh","family":"Baharlouei Yancheshmeh","sequence":"additional","affiliation":[{"name":"Cardiology Department, Abadan University of Medical Science, Abadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9531-2351","authenticated-orcid":false,"given":"Parisa","family":"Adib-Hajbagheri","sequence":"additional","affiliation":[{"name":"Cardiology Department, Abadan University of Medical Science, Abadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Amerizadeh","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-5751","authenticated-orcid":false,"given":"Raheleh","family":"Karimi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10550881003684798","article-title":"Pharmacotherapy in the treatment of addiction: methadone.","volume":"29","author":"Kreek","year":"2010","journal-title":"J Addict Dis"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"1615; author reply 1615","DOI":"10.1001\/archinte.163.13.1615-a","article-title":"Synthetic opioids and QT prolongation.","volume":"163","author":"Krantz","year":"2003","journal-title":"Arch Intern Med"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go-related gene K+ currents.","volume":"303","author":"Katchman","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R4-20261118","first-page":"17","article-title":"The effectiveness of methadone maintenance therapy among opiate - dependants registered with Hospital Raja Perempuan Zainab II Kota Bharu, Kelantan.","volume":"19","author":"Premila Devi","year":"2012","journal-title":"Malays J Med Sci"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugpo.2009.03.001","article-title":"A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.","volume":"21","author":"Zamani","year":"2010","journal-title":"Int J Drug Policy"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0376-8716(03)00187-X","article-title":"A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.","volume":"72","author":"Dolan","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0376-8716(00)00211-8","article-title":"Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study.","volume":"62","author":"Gossop","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s40265-025-02189-7","article-title":"QT prolongation and risk of death with the use of methadone for chronic cancer and noncancer pain: myths or reality?","volume":"85","author":"Mercadante","year":"2025","journal-title":"Drugs"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpain.2014.01.495","article-title":"Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American pain society and college on problems of drug dependence clinical practice guideline.","volume":"15","author":"Chou","year":"2014","journal-title":"J Pain"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10840-015-0077-2","article-title":"Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?","volume":"45","author":"Romero","year":"2016","journal-title":"J Interventional Cardiac Electrophysiol"},{"key":"R11-20261118","first-page":"470","article-title":"Methadone-associated QTc prolongation: a case report and review of the literature.","volume":"10","author":"Abramson","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"577","DOI":"10.17179\/excli2014-553","article-title":"A systematic review of the cardiotoxicity of methadone.","volume":"14","author":"Alinejad","year":"2015","journal-title":"Excli J"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.hrthm.2011.07.023","article-title":"Left cardiac sympathetic denervation for the treatment of methadone-induced long QT syndrome.","volume":"8","author":"Miller","year":"2011","journal-title":"Heart Rhythm"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mayocp.2013.01.013","article-title":"Institution-wide QT alert system identifies patients with a high risk of mortality.","volume":"88","author":"Haugaa","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jemermed.2004.10.022","article-title":"Methadone-induced bradycardia.","volume":"29","author":"Ashwath","year":"2005","journal-title":"J Emerg Med"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"218; author reply 218","DOI":"10.7326\/0003-4819-151-3-200908040-00016","article-title":"Concerns about consensus guidelines for QTc interval screening in methadone treatment.","volume":"151","author":"Bart","year":"2009","journal-title":"Ann Intern Med"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0002-9149(02)02337-8","article-title":"Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc.","volume":"89","author":"Bednar","year":"2002","journal-title":"Am J Cardiol"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.hrthm.2005.07.017","article-title":"Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians.","volume":"2","author":"Heist","year":"2005","journal-title":"Heart Rhythm"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening in methadone treatment.","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.hrthm.2017.03.014","article-title":"Acquired long QT syndrome in hospitalized patients.","volume":"14","author":"Yu","year":"2017","journal-title":"Heart Rhythm"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1360-0443.2009.02549.x","article-title":"Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.","volume":"104","author":"Anchersen","year":"2009","journal-title":"Addiction"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1540-8167.2011.02231.x","article-title":"Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.","volume":"23","author":"Chang","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpainsymman.2004.06.012","article-title":"Measurement of QTc in patients receiving chronic methadone therapy.","volume":"29","author":"Cruciani","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2459\/JCM.0b013e32834033f2","article-title":"Cardiovascular-associated disease in an addicted population: an observation study.","volume":"12","author":"Demarie","year":"2011","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med"},{"key":"R29-20261118","first-page":"264","article-title":"Evaluation of QTc interval in Iranian causalities (Janbazan) of Iran-Iraq war receiving maintenance methadone treatment.","volume":"17","author":"Esfahani","year":"2012","journal-title":"J Res Med Sci"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/hrt.2006.100180","article-title":"Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.","volume":"93","author":"Fanoe","year":"2007","journal-title":"Heart"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00952990.2013.804525","article-title":"QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.","volume":"39","author":"Fareed","year":"2013","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12012-014-9259-x","article-title":"The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdose.","volume":"14","author":"Farsi","year":"2014","journal-title":"Cardiovasc Toxicol"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"e23819","DOI":"10.5812\/ijhrba.4(2)2015.23819","article-title":"QTc prolongation in veterans with heroin dependence on methadone maintenance treatment.","volume":"4","author":"Hassamal","year":"2015","journal-title":"Int J High Risk Behav Addict"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.amjcard.2013.05.037","article-title":"QTc interval screening in an opioid treatment program.","volume":"112","author":"Katz","year":"2013","journal-title":"Am J Cardiol"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/10550880802324317","article-title":"Heterogeneous impact of methadone on the QTc interval: what are the practical implications?","volume":"27","author":"Krantz","year":"2008","journal-title":"J Addict Dis"},{"key":"R36-20261118","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000081416","article-title":"QTc interval prolongation in patients on long-term methadone maintenance therapy.","volume":"11","author":"Maremmani","year":"2005","journal-title":"Eur Addict Res"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1465-3362.2010.00237.x","article-title":"Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?","volume":"30","author":"Mayet","year":"2011","journal-title":"Drug Alcohol Rev"},{"key":"R38-20261118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1360-0443.2006.01668.x","article-title":"Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.","volume":"102","author":"Peles","year":"2007","journal-title":"Addiction"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1472-8206.2010.00871.x","article-title":"QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.","volume":"25","author":"Perrin-Terrin","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"key":"R40-20261118","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3390\/biomedicines11082109","article-title":"Methadone maintenance and QT-interval: prevalence and risk factors-is it effective to switch therapy to levomethadone?","volume":"11","author":"Santin","year":"2023","journal-title":"Biomedicines"},{"key":"R41-20261118","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/phar.2498","article-title":"Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program.","volume":"41","author":"Titus-Lay","year":"2021","journal-title":"Pharmacotherapy"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/jpm12050835","article-title":"Association of a common NOS1AP variant with attenuation of QTc prolongation in men with heroin dependence undergoing methadone treatment.","volume":"12","author":"Chang","year":"2022","journal-title":"J Pers Med"},{"key":"R43-20261118","first-page":"9","article-title":"A retrospective longitudinal cohort study: the effect of long-term use of methadone and associated factors on QTc in a maintenance program.","volume":"9","author":"Deuss","year":"2024","journal-title":"Int Arch Addict Res Med"},{"key":"R45-20261118","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2012.09.016","article-title":"Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.","volume":"129","author":"Stallvik","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R46-20261118","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/fcp.12405","article-title":"QT length during methadone maintenance treatment: gene \u00d7 dose interaction.","volume":"33","author":"Zerdazi","year":"2019","journal-title":"Fundam Clin Pharmacol"},{"key":"R47-20261118","doi-asserted-by":"crossref","first-page":"e0322724","DOI":"10.1371\/journal.pone.0322724","article-title":"A synonymous KCNH2 polymorphism and methadone trough level influence QTc prolongation in Kelantanese Malay recipients of methadone maintenance therapy (MMT) in Malaysia.","volume":"20","author":"Abdul Jalal","year":"2025","journal-title":"PLoS One"},{"key":"R48-20261118","doi-asserted-by":"crossref","first-page":"e86114","DOI":"10.1371\/journal.pone.0086114","article-title":"Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.","volume":"9","author":"Dennis","year":"2014","journal-title":"PLoS One"},{"key":"R49-20261118","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/2045125312469982","article-title":"Methadone, QTc interval prolongation and torsade de pointes: case reports offer the best understanding of this problem.","volume":"3","author":"Vieweg","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"R50-20261118","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes.","volume":"67","author":"Schwartz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R51-20261118","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","article-title":"Clinical and genetic determinants of torsade de pointes risk.","volume":"125","author":"Sauer","year":"2012","journal-title":"Circulation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:00:31Z","timestamp":1795021231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":49,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045304","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}